INTERCURE
InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases. The Company has incorporated its "Interactive Respiratory-Pacing" technology platform into several product lines, the first two of which offer a new therapeutic class of non-drug treatments for two of the most widespread and costly disease states in the healthcare industry: hypertension and heart failure. InterCureโs first marke... t-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side effects. InterCure's heart failure product, InToneโข has successfully completed phase 2a efficacy clinical trials and is expected to be launched when it completes the regulatory approval process. With its outstanding management team, the board of directors and a world-class Scientific Advisory Board, Intercure is poised to become the market leader in patient-focused medical devices that provide non-drug, no-side-effect treatment for some of the world's most prevalent and costly chronic conditions. InterCure was founded in 1994 and is headquartered in Ra'anana, Israel.
INTERCURE
Industry:
Health Care Manufacturing Medical Device Therapeutics
Founded:
1994-01-01
Address:
Ra'anana, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.intercure.com
Total Employee:
51+
Status:
Active
Contact:
201-720-7750
Email Addresses:
[email protected]
Total Funding:
41.9 M USD
Technology used in webpage:
SPF Nginx Citrix NetScaler DOSarrest Uniregistry
Similar Organizations
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-09-04 | Canndoc | Canndoc acquired by InterCure | N/A |
Investors List
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - InterCure
Adam Neumann
Adam Neumann investment in Post-IPO Equity - InterCure
GMF Capital
GMF Capital investment in Post-IPO Equity - InterCure
Nippon Venture Capital
Nippon Venture Capital investment in Series C - InterCure
Medica Venture Partners
Medica Venture Partners investment in Series C - InterCure
Arie Ovadia
Arie Ovadia investment in Series B - InterCure
Palladin Consumer Retail Partners
Palladin Consumer Retail Partners investment in Series B - InterCure
Daniel Plotkin
Daniel Plotkin investment in Series B - InterCure
Medica Venture Partners
Medica Venture Partners investment in Series B - InterCure
True North Partners
True North Partners investment in Series B - InterCure
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-12-23 | Fore Biotherapeutics | InterCure investment in Venture Round - Fore Biotherapeutics | 10 M USD |
Official Site Inspections
http://www.intercure.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "InterCure"
InterCure - Crunchbase Company Profile & Funding
InterCureโs first market-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side โฆSee details»
INTERCURE LTD.
InterCure (dba Canndoc) (NASDAQ: INCR) (TASE: INCR) is the leading, profitable, and fastest-growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of โฆSee details»
InterCure Ltd. (INCR.TA) Company Profile & Facts - Yahoo Finance
See the company profile for InterCure Ltd. (INCR.TA) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
InterCure - Crunchbase Company Profile & Funding
Organization. InterCure . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. InterCure is a manufacturer and distributor of pharmaceutical medical cannabis products. ...See details»
InterCure - Funding, Financials, Valuation & Investors - Crunchbase
InterCure is registered under the ticker TLV:INCR . InterCure is funded by 12 investors. ARK Investment Management and Adam Neumann are the most recent investors. InterCure has โฆSee details»
Intercure Ltd, INCR:TLV profile - FT.com - Financial Times
Dec 2, 2024 InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis โฆSee details»
InterCure - Overview, News & Similar companies | ZoomInfo.com
Jun 11, 2020 InterCure. Manufacturing · New York, United States · 50 Employees. View Company Info for Free. About. Headquarters 589 8th Ave Fl 6, New York City, New York, โฆSee details»
InterCure - businessabc.net
Dec 8, 2024 InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and โฆSee details»
Intercure Inc. Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Intercure Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
InterCure Ltd. (INCR) Company Profile & Facts - Yahoo Finance
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in โฆSee details»
InterCure Ltd. (INCR) Company Profile & Overview - Stock Analysis
5 days ago InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products โฆSee details»
Company InterCure Ltd. - MarketScreener.com
Dec 13, 2014 InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis โฆSee details»
Governance InterCure Ltd. Toronto S.E. - MarketScreener.com
Dec 31, 2009 InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis โฆSee details»
InterCure - Overview, News & Similar companies | ZoomInfo.com
InterCure is the leading, fastest growing and the most profitable Israeli cannabis company. InterCure leverages its market leading distribution network, best in class international โฆSee details»
InterCure Continuing its Medical Cannabis Consolidation Strategy ...
Sep 2, 2021 "Intercure is further capitalizing on its growth momentum, which is supporting our move of leading the consolidation of the medical cannabis market," said InterCure CFO, Amos โฆSee details»
InterCure - Funding, Financials, Valuation & Investors - Crunchbase
InterCure is a manufacturer and distributor of pharmaceutical medical cannabis products. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How โฆSee details»
InterCure Ltd. (TLV: INCR) Stock Price & Overview - Stock Analysis
2 days ago InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products โฆSee details»
Organigram and InterCure Sign New International Strategic โฆ
Organigram and InterCure entered into a previous strategic supply agreement in June 2020, (the โFirst Strategic Agreementโ) that contemplated a minimum supply of 3,000 kg all of which has โฆSee details»